Aussie micro on New Year high after landing first China customers
Health & Biotech
Health & Biotech
Special Report: ASX-listed health and wellness company, EVE Investments, has secured its first purchase orders in China for over 21,000 units of Meluka Honey as the company unveils a new product range and announces further plans for growth.
EVE Investments (ASX:EVE) has wasted no time in getting its new year’s resolutions ticked off the list.
The company, a leading vertically integrated producer of branded nutrition, health and wellness products, has kicked off 2020 in style after receiving a sizeable order of 21,144 units of Meluka Honey – part of its premium consumer branded range produced in the heart of Alstonville in northern New South Wales.
The deal, which sees shipment commence at the end of this month, came off the back of a December product launch in Guangzhou to Hunan Yandi Bioengineering, a Chinese green life and health care distribution giant with over 1 million members in its distribution network.
After successfully closing its first tranche share subscription and with the second tranche about to close, the company has secured important working capital to fund its sales and marketing programs across Australia, Asia Pacific and North America over the next three years and remains poised to accelerate the roll-out of new additions to its honey product range.
Buoyed by the significant interest the company has received in its Meluka Australia offerings in China to date, EVE Investments managing director Bill Fry said this was an important milestone for the company as it looked to go after markets with sizeable commercial potential in the year ahead.
“We are pleased to have begun 2020 strongly with a number of key milestones including our expansion to China, the receipt of our first purchase orders in the region and the incredible growing interest in our Meluka Australia offerings in the US,” Fry said.
“Both represent key target markets for EVE and the initial response that we have received from our December launch in China has been overwhelmingly positive.”
EVE’s Meluka Honey has also won over a growing swathe of customers in North America after a sustained period of high sales activity. Since the appointment of Buy Box Experts to manage the company’s Amazon strategy, sales have continued to grow month on month.
A further 9,000 units of its premium Meluka Honey range are to be shipped across to the US later this month, and the company has appointed Utah-based marketing agency Revity as part of a targeted approach towards increasing its local footprint.
EVE has also said that plans to diversify its product range were in full swing with the additions of two tea tree oil branded offerings – both sourced from Jenbrook Farms in the renowned Bungawalbin valley region – expected to be unveiled in February.
Now, with Meluka readying to launch its first bio-fermented honey and lemon drink in China and Australia next month, and subsequent launches
in the US and Japan planned for March, Fry senses that 2020 will be “an exciting year” for the company.
“China has consistently shown itself to be the number one export country for honey by volume over the last 10 years and the possibilities for scale cannot be ignored,” Fry said.
“Our go-to-market strategy is anchored in expanding the reach and penetration of our iconic premium branded products by taking them to global audiences.”